|
US2007265432A1
|
|
Multiplex-bead complex for determination of lysosomal storage disorders
|
|
US2005142590A1
|
|
Diagnosis of lysosomal storage disorders using saposins and other markers
|
|
NZ543309A
|
|
Multiplex screening for lysosomal storage disorders (LSDs)
|
|
AU2003285974A1
|
|
Modified lacz gene
|
|
WO2004050872A1
|
|
Modified lacz gene
|
|
AU2003902390A0
|
|
Non-invasive method of assessing gastrointestinal damage
|
|
AU2003901451A0
|
|
An improved method of screening for lysosomal storage disorders (LSD)
|
|
AU2003209813A1
|
|
Therapeutic properties of oils
|
|
AU2002952992A0
|
|
A novel method for the diagnosis of urinary tract infections
|
|
AUPS293002A0
|
|
Identification of oligosaccharides and their use in the diagnosis and evaluation of mucopolysaccharidoses and other related disorders
|
|
AUPS082102A0
|
|
Therapeutic properties of oils
|
|
AUPR905901A0
|
|
A novel method for the diagnosis of urinary tract infections
|
|
AUPR894201A0
|
|
Respiratory delivery for gene therapy and lentiviral delivery particle
|
|
AUPR690601A0
|
|
Toxin associated with sudden infant death syndrome, and uses thereof
|
|
TWI243053B
|
|
Anti-cancer fatty acids and lipids and analogues and pharmaceutical compositions thereof
|
|
WO0144466A1
|
|
Oxidoreductase gene associated with the fra16d fragile site
|
|
AU2129001A
|
|
Oxidoreductase gene associated with the fra16d fragile site
|
|
AUPR195900A0
|
|
Detection of compounds such as thyroxine
|
|
AU7034900A
|
|
Recombinant microorganisms expressing an oligosaccharide receptor mimic
|
|
AUPQ702500A0
|
|
For proteins, nucleic acids and methods based thereon
|
